Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2022 Filed Mar 7, 2022 22:42 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
Tax withholdingCommon Stock | 10,290 | $15.81 | $162,684.90 |
DisclosureSEC source: 0001209191-22-016780 · doc4.xml · nonDerivative · entry 2 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,109 F2 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock issued on March 3, 2022. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 22:42 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
GrantCommon Stock | 23,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016780 · doc4.xml · nonDerivative · entry 1 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,399 F1 · shares: The Reporting Person has been awarded 23,516 shares of restricted stock under the Issuer's 2015 Incentive Plan as payout under the 2021 Bonus Plan. These shares vested in full upon grant. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 22:41 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
Tax withholdingCommon Stock | 39,789 | $15.81 | $629,064.09 |
DisclosureSEC source: 0001209191-22-016776 · doc4.xml · nonDerivative · entry 2 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,981 F2 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock issued on March 3, 2022. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 22:41 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
GrantCommon Stock | 80,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016776 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,770 F1 · shares: The Reporting Person has been awarded 80,626 shares of restricted stock under the Issuer's 2015 Incentive Plan as payout under the 2021 Bonus Plan. These shares vested in full upon grant. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 22:40 UTC |
Ellis MennoEVP, Healthcare Solutions
|
Tax withholdingCommon Stock | 9,229 | $15.81 | $145,910.49 |
DisclosureSEC source: 0001209191-22-016772 · doc4.xml · nonDerivative · entry 2 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,114 F2 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock issued on March 3, 2022. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 22:40 UTC |
Ellis MennoEVP, Healthcare Solutions
|
GrantCommon Stock | 23,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016772 · doc4.xml · nonDerivative · entry 1 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,343 F1 · shares: The Reporting Person has been awarded 23,453 shares of restricted stock under the Issuer's 2015 Incentive Plan as payout under the 2021 Bonus Plan. These shares vested in full upon grant. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 22:39 UTC |
Crimmins Michael SSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 2,862 | $15.81 | $45,248.22 |
DisclosureSEC source: 0001209191-22-016770 · doc4.xml · nonDerivative · entry 2 Crimmins Michael S · CIK 0001676157 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,294 F2 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock issued on March 3, 2022. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 22:39 UTC |
Crimmins Michael SSVP, Chief Accounting Officer
|
GrantCommon Stock | 8,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016770 · doc4.xml · nonDerivative · entry 1 Crimmins Michael S · CIK 0001676157 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,156 F1 · shares: The Reporting Person has been awarded 8,042 shares of restricted stock under the Issuer's 2015 Incentive Plan as payout under the 2021 Bonus Plan. These shares vested in full upon grant. Read SEC document |
| March 01, 2022 Filed Mar 1, 2022 21:14 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 4,000 | $20.00 | $80,000.00 |
DisclosureSEC source: 0001209191-22-013984 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,015 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 18, 2021. Read SEC document |
| February 22, 2022 Filed Feb 22, 2022 21:17 UTC |
Narula JagtarEVP & Chief Financial Officer
|
SaleCommon Stock | 5,863 | $16.95 | $99,377.85 |
DisclosureSEC source: 0001209191-22-011647 · doc4.xml · nonDerivative · entry 1 Narula Jagtar · CIK 0001824593 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,107 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on August 27, 2021. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 21:20 UTC |
Puthenveetil RejiEVP, Industrial Solutions
|
SaleCommon Stock | 600 | $16.98 | $10,185.00 |
DisclosureSEC source: 0001209191-22-012181 · doc4.xml · nonDerivative · entry 1 Puthenveetil Reji · CIK 0001826896 · EVP, Industrial Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,211 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.94 to $17.02, inclusive. The reporting person undertakes to provide to 3D Systems Corporation, any security holder of 3D Systems Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 2 of this Form 4. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Ellis MennoEVP, Healthcare Solutions
|
Tax withholdingCommon Stock | 3,608 | $19.38 | $69,923.04 |
DisclosureSEC source: 0001209191-22-010844 · doc4.xml · nonDerivative · entry 2 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,890 F2 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on February 18, 2020. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Ellis MennoEVP, Healthcare Solutions
|
Tax withholdingCommon Stock | 2,397 | $19.38 | $46,453.86 |
DisclosureSEC source: 0001209191-22-010844 · doc4.xml · nonDerivative · entry 1 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,498 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on February 15, 2019. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:05 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
Tax withholdingCommon Stock | 4,671 | $19.38 | $90,523.98 |
DisclosureSEC source: 0001209191-22-010851 · doc4.xml · nonDerivative · entry 2 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,015 F2 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on February 18, 2020. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:05 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
Tax withholdingCommon Stock | 3,671 | $19.38 | $71,143.98 |
DisclosureSEC source: 0001209191-22-010851 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,686 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on February 15, 2019. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:04 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
Tax withholdingCommon Stock | 3,515 | $19.38 | $68,120.70 |
DisclosureSEC source: 0001209191-22-010848 · doc4.xml · nonDerivative · entry 2 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,883 F2 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on February 18, 2020. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:04 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
Tax withholdingCommon Stock | 2,140 | $19.38 | $41,473.20 |
DisclosureSEC source: 0001209191-22-010848 · doc4.xml · nonDerivative · entry 1 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,398 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on February 15, 2019. Read SEC document |
| February 01, 2022 Filed Feb 1, 2022 21:37 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 4,000 | $18.50 | $74,000.00 |
DisclosureSEC source: 0001209191-22-005924 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,357 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 18, 2021. Read SEC document |
| January 21, 2022 Filed Jan 21, 2022 21:16 UTC |
Narula JagtarEVP & Chief Financial Officer
|
SaleCommon Stock | 5,863 | $17.99 | $105,475.37 |
DisclosureSEC source: 0001209191-22-004408 · doc4.xml · nonDerivative · entry 1 Narula Jagtar · CIK 0001824593 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,970 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on August 27, 2021. Read SEC document |
| January 21, 2022 Filed Jan 24, 2022 21:17 UTC |
Puthenveetil RejiEVP, Industrial Solutions
|
SaleCommon Stock | 600 | $17.77 | $10,660.80 |
DisclosureSEC source: 0001209191-22-004597 · doc4.xml · nonDerivative · entry 1 Puthenveetil Reji · CIK 0001826896 · EVP, Industrial Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,811 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.70 to $18.02, inclusive. The reporting person undertakes to provide to 3D Systems Corporation, any security holder of 3D Systems Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 2 of this Form 4. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 21:18 UTC |
Puthenveetil RejiEVP, Industrial Solutions
|
Tax withholdingCommon Stock | 6,048 | $20.18 | $122,048.64 |
DisclosureSEC source: 0001209191-22-003333 · doc4.xml · nonDerivative · entry 1 Puthenveetil Reji · CIK 0001826896 · EVP, Industrial Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,411 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 21:17 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
Tax withholdingCommon Stock | 5,347 | $20.18 | $107,902.46 |
DisclosureSEC source: 0001209191-22-003330 · doc4.xml · nonDerivative · entry 2 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,357 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 21:17 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
Tax withholdingCommon Stock | 5,413 | $20.18 | $109,234.34 |
DisclosureSEC source: 0001209191-22-003330 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,704 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 21:18 UTC |
Narula JagtarEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 6,689 | $20.18 | $134,984.02 |
DisclosureSEC source: 0001209191-22-003331 · doc4.xml · nonDerivative · entry 1 Narula Jagtar · CIK 0001824593 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,833 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 21:16 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
Tax withholdingCommon Stock | 5,299 | $20.18 | $106,933.82 |
DisclosureSEC source: 0001209191-22-003328 · doc4.xml · nonDerivative · entry 2 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,538 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 21:16 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
Tax withholdingCommon Stock | 3,119 | $20.18 | $62,941.42 |
DisclosureSEC source: 0001209191-22-003328 · doc4.xml · nonDerivative · entry 1 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,837 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 21:16 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
Tax withholdingCommon Stock | 17,759 | $20.18 | $358,376.62 |
DisclosureSEC source: 0001209191-22-003327 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,144 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 21:15 UTC |
Ellis MennoEVP, Healthcare Solutions
|
Tax withholdingCommon Stock | 5,407 | $20.18 | $109,113.26 |
DisclosureSEC source: 0001209191-22-003324 · doc4.xml · nonDerivative · entry 1 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,895 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on January 12, 2021. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:16 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
Tax withholdingCommon Stock | 53,715 | $21.54 | $1,157,021.10 |
DisclosureSEC source: 0001209191-22-000699 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,903 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock units originally made on May 26, 2020. Read SEC document |
| December 27, 2021 Filed Dec 27, 2021 21:16 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 4,000 | $21.81 | $87,240.00 |
DisclosureSEC source: 0001209191-21-071245 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,117 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 18, 2021. Read SEC document |
| December 21, 2021 Filed Dec 21, 2021 21:16 UTC |
Narula JagtarEVP & Chief Financial Officer
|
SaleCommon Stock | 5,863 | $21.50 | $126,054.50 |
DisclosureSEC source: 0001209191-21-070770 · doc4.xml · nonDerivative · entry 1 Narula Jagtar · CIK 0001824593 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,522 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on August 27, 2021. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 22:05 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
Tax withholdingCommon Stock | 1,871 | $21.33 | $39,908.43 |
DisclosureSEC source: 0001209191-21-069779 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,117 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on December 13, 2019. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 22:03 UTC |
Ellis MennoEVP, Healthcare Solutions
|
Tax withholdingCommon Stock | 1,639 | $21.33 | $34,959.87 |
DisclosureSEC source: 0001209191-21-069777 · doc4.xml · nonDerivative · entry 1 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,302 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on December 13, 2019. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 21:57 UTC |
HULL CHARLES WDirector · EVP & CTO (Regenerative Med)
|
Tax withholdingCommon Stock | 1,651 | $21.33 | $35,215.83 |
DisclosureSEC source: 0001209191-21-069773 · doc4.xml · nonDerivative · entry 1 HULL CHARLES W · CIK 0001105964 · Director · EVP & CTO (Regenerative Med) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,956 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on December 13, 2019. F2 · balance_after: Amount of securities beneficially owned decreased by 74,510 shares to reflect the transfer of such shares from direct ownership by the Reporting Person to indirect ownership as further described in footnote (3). Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 21:31 UTC |
Drayton ClaudiaDirector
|
GrantCommon Stock | 6,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-067593 · doc4.xml · nonDerivative · entry 1 Drayton Claudia · CIK 0001629827 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,752 F1 · price: A total of 6,752 shares were awarded to the Reporting Person under the Issuer's Amended and Restated 2015 Incentive Plan. Read SEC document |
| November 26, 2021 Filed Nov 29, 2021 21:15 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 4,000 | $22.57 | $90,280.00 |
DisclosureSEC source: 0001209191-21-066986 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,988 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 18, 2021. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:16 UTC |
Narula JagtarEVP & Chief Financial Officer
|
SaleCommon Stock | 5,863 | $24.40 | $143,057.20 |
DisclosureSEC source: 0001209191-21-066410 · doc4.xml · nonDerivative · entry 1 Narula Jagtar · CIK 0001824593 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,385 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on August 27, 2021. Read SEC document |
| October 26, 2021 Filed Oct 26, 2021 20:22 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 4,000 | $28.71 | $114,840.00 |
DisclosureSEC source: 0001209191-21-061629 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,988 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 18, 2021. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 20:17 UTC |
Puthenveetil RejiEVP, Industrial Solutions
|
Tax withholdingCommon Stock | 14,634 | $27.67 | $404,922.78 |
DisclosureSEC source: 0001209191-21-058936 · doc4.xml · nonDerivative · entry 1 Puthenveetil Reji · CIK 0001826896 · EVP, Industrial Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,459 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on October 5, 2020. Read SEC document |
| September 27, 2021 Filed Sep 27, 2021 20:13 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 4,000 | $29.10 | $116,400.00 |
DisclosureSEC source: 0001209191-21-057776 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,988 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 18, 2021. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 21:02 UTC |
Narula JagtarEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 71,407 | $29.88 | $2,133,641.16 |
DisclosureSEC source: 0001209191-21-056192 · doc4.xml · nonDerivative · entry 1 Narula Jagtar · CIK 0001824593 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,248 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on September 14, 2020. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 20:16 UTC |
Nordstrom Phyllis BEVP & CHRO
|
GrantCommon Stock | 17,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054069 · doc4.xml · nonDerivative · entry 2 Nordstrom Phyllis B · CIK 0001879982 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,470 F2 · shares: The Reporting Person has been awarded 17,059 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on August 30, 2022, an additional one-third of the total shares awarded vest on August 30, 2023, and the remaining shares awarded vest on August 30, 2024, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 20:16 UTC |
Nordstrom Phyllis BEVP & CHRO
|
GrantCommon Stock | 3,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054069 · doc4.xml · nonDerivative · entry 1 Nordstrom Phyllis B · CIK 0001879982 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,411 F1 · shares: The Reporting Person has been awarded 3,411 shares of restricted stock under the Issuer's 2015 Incentive Plan. These shares of restricted stock will vest one year from the date of grant. Read SEC document |
| August 26, 2021 Filed Aug 26, 2021 20:12 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 4,000 | $29.41 | $117,640.00 |
DisclosureSEC source: 0001209191-21-053463 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,988 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 18, 2021. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 21:07 UTC |
GRAVES JEFFREY ADirector · President and CEO
|
PurchaseCommon Stock | 4,260 | $29.37 | $125,116.20 |
DisclosureSEC source: 0001209191-21-051930 · doc4.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,618 F1 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.86 to $29.50, inclusive. The reporting person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 of this Form 4. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 20:12 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 4,000 | $25.80 | $103,200.00 |
DisclosureSEC source: 0001209191-21-048170 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,988 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 18, 2021. Read SEC document |
| July 17, 2021 Filed Jul 20, 2021 20:16 UTC |
Ellis MennoEVP, Healthcare Solutions
|
Tax withholdingCommon Stock | 1,372 | $25.90 | $35,534.80 |
DisclosureSEC source: 0001209191-21-047367 · doc4.xml · nonDerivative · entry 1 Ellis Menno · CIK 0001818316 · EVP, Healthcare Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,941 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on July 17, 2020. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 20:26 UTC |
Leigh David KEVP & CTO (Additive Mfg)
|
GrantCommon Stock | 20,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043983 · doc4.xml · nonDerivative · entry 1 Leigh David K · CIK 0001870051 · EVP & CTO (Additive Mfg) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,051 F1 · shares: The Reporting Person has been awarded 20,421 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on June 28, 2022, an additional one-third of the total shares awarded vest on June 28, 2023, and the remaining shares awarded vest on June 28, 2024. Read SEC document |
| June 25, 2021 Filed Jun 25, 2021 20:08 UTC |
Johnson Andrew MartinEVP, Chief Legal Officer & Sec
|
SaleCommon Stock | 4,000 | $38.20 | $152,800.00 |
DisclosureSEC source: 0001209191-21-043288 · doc4.xml · nonDerivative · entry 1 Johnson Andrew Martin · CIK 0001548887 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,988 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 18, 2021. Read SEC document |
| June 13, 2021 Filed Jun 15, 2021 16:20 UTC |
Blank JeffEVP, Engineering and Prod Dev
|
Tax withholdingCommon Stock | 985 | $29.35 | $28,909.75 |
DisclosureSEC source: 0001209191-21-040574 · doc4.xml · nonDerivative · entry 1 Blank Jeff · CIK 0001839116 · EVP, Engineering and Prod Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,229 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on June 13, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.